Association of Preoperative Antiviral Treatment with Incidences of Microvascular Invasion and early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma

As reported in MDLinx,researchers assessed how preoperative antiviral treatment (AVT) correlates with the incidences of microvascular invasion (MVI) and posthepatectomy early tumor recurrence in hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC). They found that an independent risk factor for MVI was high preoperative HBV DNA level. Following partial hepatectomy for HBV-related HCC, reduced incidences of MVI and early tumor recurrence were reported in relation to antiviral treatment administered more than 90 days before surgery.

Research/Investigative Site

Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China....

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee